Condition: Primary Open Angle Glaucoma · Sponsor: Nova Eye, Inc.
A prospective, multicenter, randomized, single-masked, post-market clinical trial comparing cataract surgery in conjunction with ab-interno canaloplasty utilizing the iTrack Advance canaloplasty device (Nova Eye, Inc.) to cataract surgery only in patients with mild to moderate, primary open angle glaucoma. Subjects will be followed for 24 months.
This description comes directly from the study's public registry record.
Mike Pickrel · 800-391-2316 · MPickrel@Nova-Eye.com
Always discuss trial participation with your own doctor first.
| Berkeley Eye Center | Sugar Land, Texas, United States | Recruiting |
| University of Bonn Eye Clinic | Bonn, Germany | Recruiting |
| Augencentrum Köln Ophthalmology | Cologne, Germany | Recruiting |
| St. Johannes Hospital | Dortmund, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05564091